Works by Weberpals, Johanne

Results: 8

Retrospective analysis of Schlafen11 (SLFN11) to predict the outcomes to therapies affecting the DNA damage response.

Published in:

2021

By:

Willis, Sophie E.;
Winkler, Claudia;
Roudier, Martine P.;
Baird, Tarrion;
Marco-Casanova, Paola;
Jones, Emma V.;
Rowe, Philip;
Rodriguez-Canales, Jaime;
Angell, Helen K.;
Ng, Felicia S. L.;
Waring, Paul M.;
Hodgson, Darren;
Ledermann, Jonathan A.;
Weberpals, Johanne I.;
Dean, Emma;
Harrington, Elizabeth A.;
Barrett, J. Carl;
Pierce, Andrew J.;
Leo, Elisabetta;
Jones, Gemma N.

Publication type:

journal article

A phase I study of high-dose rosuvastatin with standard dose erlotinib in patients with advanced solid malignancies.

Published in:

2016

By:

Goss, Glenwood D.;
Jonker, Derek J.;
Laurie, Scott A.;
Weberpals, Johanne I.;
Oza, Amit M.;
Spaans, Johanna N.;
la Porte, Charles;
Dimitroulakos, Jim

Publication type:

journal article

Pathology cancer clinic: An innovative model to enhance the quality of patient care for women with gynecologic cancer at the Ottawa Hospital.

Published in:

Canadian Journal of Pathology, 2018, v. 10, p. 29

By:

Khan, Osama A.;
Lafreniere, Anthea J.;
Busca, Aurelia;
Gray, George;
Petkiewicz, Stephanie;
Williams, K.;
Tien Le;
Weberpals, Johanne L.;
Hopkins, Laura;
Islam, Shahidul

Publication type:

Article

Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum‐based regimen and disease at baseline on efficacy and safety.

Published in:

Cancer Medicine, 2021, v. 10, n. 20, p. 7162, doi. 10.1002/cam4.4260

By:

Oaknin, Ana;
Oza, Amit M.;
Lorusso, Domenica;
Aghajanian, Carol;
Dean, Andrew;
Colombo, Nicoletta;
Weberpals, Johanne I.;
Clamp, Andrew R.;
Scambia, Giovanni;
Leary, Alexandra;
Holloway, Robert W.;
Amenedo Gancedo, Margarita;
Fong, Peter C.;
Goh, Jeffrey C.;
O'Malley, David M.;
Armstrong, Deborah K.;
Banerjee, Susana;
García‐Donas, Jesus;
Swisher, Elizabeth M.;
Cameron, Terri

Publication type:

Article

Tumor genomic, transcriptomic, and immune profiling characterizes differential response to first‐line platinum chemotherapy in high grade serous ovarian cancer.

Published in:

Cancer Medicine, 2021, v. 10, n. 9, p. 3045, doi. 10.1002/cam4.3831

By:

Weberpals, Johanne I.;
Pugh, Trevor J.;
Marco‐Casanova, Paola;
Goss, Glenwood D.;
Andrews Wright, Natalie;
Rath, Prisni;
Torchia, Jonathon;
Fortuna, Alexander;
Jones, Gemma N.;
Roudier, Martine P.;
Bernard, Laurence;
Lo, Bryan;
Torti, Dax;
Leon, Alberto;
Marsh, Kayla;
Hodgson, Darren;
Duciaume, Marc;
Howat, William J.;
Lukashchuk, Natalia;
Lazic, Stanley E.

Publication type:

Article

Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer.

Published in:

2013

By:

Koti, Madhuri;
Gooding, Robert J.;
Nuin, Paulo;
Haslehurst, Alexandria;
Crane, Colleen;
Weberpals, Johanne;
Childs, Timothy;
Bryson, Peter;
Dharsee, Moyez;
Evans, Kenneth;
Feilotter, Harriet E.;
Park, Paul C.;
Squire, Jeremy A.

Publication type:

journal article

Sensitivity of cervical carcinoma cells to vesicular stomatitis virus-induced oncolysis: Potential role of human papilloma virus infection.

Published in:

International Journal of Cancer, 2012, v. 131, n. 3, p. E204, doi. 10.1002/ijc.27404

By:

Le Boeuf, Fabrice;
Niknejad, Nima;
Wang, Jiahu;
Auer, Rebecca;
Weberpals, Johanne I.;
Bell, John C.;
Dimitroulakos, Jim

Publication type:

Article

The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer.

Published in:

International Journal of Cancer, 2009, v. 124, n. 4, p. 806, doi. 10.1002/ijc.23987

By:

Weberpals, Johanne;
Garbuio, Kyla;
O'Brien, Anna;
Clark-Knowles, Katherine;
Doucette, Steve;
Antoniouk, Olga;
Goss, Glenwood;
Dimitroulakos, Jim

Publication type:

Article